The aim of this study is to determine the diagnostic yield of continuous 7-day Holter ECG for detecting covert paroxysmal atrial fibrillation in patients with recent embolic stroke or transient ischemic attack (TIA) of undetermined cause after completion of a standard clinical work up including an initial 24-hour Holter monitoring.
Covert atrial fibrillation (AF) is a relevant potential cause of a recently proposed clinical construct, "Embolic Stroke of Undetermined Source (ESUS)". However, routine post-stroke work up including 24-hour Holter monitoring may fail to detect paroxysmal AF. A recent systematic review has shown an increased AF detection rate with longer monitoring durations. The aim of this study is to evaluate the effectiveness of a novel ambulatory 7-day Holter ECG (EV-201, Parama-Tech inc.) for detecting AF in patients with recent ESUS after completion of a standard clinical examination.
Study Type
OBSERVATIONAL
Enrollment
200
National Cerebral and Cardiovascular Center
Suita, Osaka, Japan
RECRUITINGDetection of any atrial fibrillation
Time frame: After examination of 7-day Holter monitoring (within 90 days of stroke onset)
Change of antithrombotic drugs
Time frame: After the examination of 7-day Holter monitoring
Any ischemic or hemorrhagic event
Time frame: 365 days after index stroke
Any adverse event related to 7-day Holter monitoring
Time frame: After the examination of 7-day Holter monitoring
Time to detection of atrial fibrillation on 7-day Holter monitoring
Time frame: After the examination of 7-day Holter monitoring
Atrial fibrillation burden
defined as the total time in atrial fibrillation devided by the total monitored time
Time frame: After the examination of 7-day Holter monitoring
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.